Keyphrases
Porphyrin
100%
Human Epidermal Growth Factor Receptor 2 (HER2)
71%
Photodynamic Therapy
67%
Phthalocyanine
58%
Photosensitizer
57%
Tumor
56%
Gastric Cancer
44%
ImmunoPET
44%
Trastuzumab
42%
Galectin-1 (Gal-1)
39%
Galactose
38%
Caveolin-1 (Cav-1)
35%
Molecular Imaging
35%
Cancer Cells
30%
PET Imaging
29%
Statins
29%
Bladder Cancer Cells
27%
Photodynamic Cancer Therapy
27%
Carbohydrates
26%
Zirconium-89 (89Zr)
25%
Positron Emission Tomography
25%
Human Bladder Cancer Cells
24%
Photodynamic
24%
Gastric Tumor
22%
Glucose Transporter 1 (GLUT1)
22%
Tumor Cells
21%
Overexpressing
20%
Xenograft
20%
Epidermal Growth Factor Receptor
20%
Photodynamic Effect
19%
Protein Level
19%
Phototoxicity
18%
Patient Selection
17%
Cell Death
17%
Antibody-drug Conjugate
17%
Targeted Photodynamic Therapy (tPDT)
16%
Temporal Modulation
16%
Receptor Tyrosine Kinase
16%
Cancer Spheroids
16%
Aromatics
16%
Amphiphiles
16%
Programmed Death-ligand 1 (PD-L1)
16%
Human Serum Albumin
16%
Bladder Cancer Cell Lines
16%
In Cancer
16%
Cell Surface
15%
Optical Imaging
15%
Radioligand Therapy
15%
Bladder Tumor
14%
Patient-derived Xenograft
14%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
76%
Photodynamic Therapy
62%
Phthalocyanine
58%
Malignant Neoplasm
58%
Bladder Cancer
52%
Photosensitizer
52%
Polyethylene Terephthalate
49%
Gamma Urogastrone
44%
Porphyrin
43%
Epidermal Growth Factor Receptor 2
35%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
28%
Epidermal Growth Factor Receptor
27%
Caveolin 1
26%
Receptor
25%
Immunoglobulin
25%
Trastuzumab
22%
Galactose
22%
Zirconium 89
20%
Abdominal Cancer
20%
Stomach Tumor
17%
Protein Tyrosine Kinase
16%
Radioligand
16%
Bladder Tumor
13%
Mevinolin
12%
Cancer Model
12%
Galectin 1
12%
Statin (Protein)
10%
Phosphotransferase
10%
Carbohydrate Binding Protein
10%
Monoclonal Antibody
10%
Phototoxicity
9%
Copper 64
9%
Optical Imaging
9%
Sitagliptin
8%
Drug Antibody
8%
Guanine Quadruplex
8%
Cyclodextrin
8%
Insulin Dependent Diabetes Mellitus
8%
Galectin
8%
Phthalocyanine Derivative
8%
Porphyrin Derivative
8%
Dipeptidyl Peptidase IV Inhibitor
8%
Albumin Antibody
8%
Metformin
8%
Rat Model
8%
Fluorine 18
8%
Dendrimer
8%
Phosphotransferase Inhibitor
8%
Pancreas Cancer
8%
Phosphonate
8%
Medicine and Dentistry
Neoplasm
49%
Cancer Cell
37%
Caveolin 1
33%
Bladder Cancer
28%
Positron Emission Tomography
28%
Gamma Urogastrone
27%
Photochemotherapy
25%
Stomach Tumor
20%
Epidermal Growth Factor Receptor
19%
Receptor
19%
Tumor Cell
19%
Epidermal Growth Factor Receptor 2
18%
Porphyrin
18%
Molecular Imaging
18%
Abdominal Cancer
17%
Malignant Neoplasm
17%
Xenograft
17%
Protein Tyrosine Kinase
16%
Pancreas Cancer
16%
Phthalocyanine
16%
Photosensitizer
16%
Trastuzumab
16%
Immunoglobulin
15%
Polyethylene Terephthalate
13%
Optical Imaging
13%
Treatment Response
13%
Bladder Tumor
12%
Pancreas Adenocarcinoma
12%
Radiation Therapy
12%
Galactose
10%
Phosphotransferase
10%
Cancer Therapy
10%
Cell Death
10%
Therapeutic Agent
9%
Patient Selection
9%
In Vitro
8%
Positron Emission Tomography
8%
Amphophile
8%
Drug Efficacy
8%
Sitagliptin
8%
B-Cell Lymphoma
8%
Combination Therapy
8%
Glycon
8%
Porphyrin Derivative
8%
Phthalocyanine Derivative
8%
Albumin Antibody
8%
Phosphotransferase Inhibitor
8%
Monoclonal Antibody
8%
Radioligand
8%
Bovine Serum Albumin
8%
